Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic
25 avr. 2024 09h29 HE
|
Mainz BioMed NV
Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm
Mainz Biomed Reports Full Year 2023 Financial Results
09 avr. 2024 08h01 HE
|
Mainz BioMed NV
Mainz Biomed Reports Full Year 2023 Financial Results
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
19 mars 2024 08h01 HE
|
Mainz BioMed NV
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
18 mars 2024 08h01 HE
|
Mainz BioMed NV
Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
12 mars 2024 08h01 HE
|
Mainz BioMed NV
Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic
05 mars 2024 08h01 HE
|
Mainz BioMed NV
Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic
Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community
27 févr. 2024 08h01 HE
|
Mainz BioMed NV
Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community
Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®
22 févr. 2024 08h01 HE
|
Mainz BioMed NV
Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®
Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy
21 févr. 2024 08h01 HE
|
Mainz BioMed NV
Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy
Mainz Biomed Establishes Physician-Led Laboratory Expanding Service Offering for Privately Insured Patients in Germany
06 févr. 2024 08h01 HE
|
Mainz BioMed NV
MAINZ BIOMED ESTABLISHES PHYSICIAN-LED LABORATORY EXPANDING SERVICE OFFERING FOR PRIVATELY INSURED PATIENTS IN GERMANY